BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31925667)

  • 21. Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction.
    Rovai S; Corrà U; Piepoli M; Vignati C; Salvioni E; Bonomi A; Mattavelli I; Arcari L; Scardovi AB; Perrone Filardi P; Lagioia R; Paolillo S; Magrì D; Limongelli G; Metra M; Senni M; Scrutinio D; Raimondo R; Emdin M; Lombardi C; Cattadori G; Parati G; Re F; Cicoira M; Villani GQ; Minà C; Correale M; Frigerio M; Perna E; Mapelli M; Magini A; Clemenza F; Bussotti M; Battaia E; Guazzi M; Bandera F; Badagliacca R; Di Lenarda A; Pacileo G; Maggioni A; Passino C; Sciomer S; Sinagra G; Agostoni P;
    Eur J Heart Fail; 2019 Dec; 21(12):1586-1595. PubMed ID: 31782225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similarities and Differences Between HFmrEF and HFpEF.
    Li P; Zhao H; Zhang J; Ning Y; Tu Y; Xu D; Zeng Q
    Front Cardiovasc Med; 2021; 8():678614. PubMed ID: 34616777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Characteristics and Long-Term Outcomes of Patients with Acute Decompensated Heart Failure with Mid-Range Ejection Fraction.
    Ito M; Wada H; Sakakura K; Ibe T; Ugata Y; Fujita H; Momomura SI
    Int Heart J; 2019 Jul; 60(4):862-869. PubMed ID: 31204376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure with mid-range or mildly reduced ejection fraction.
    Savarese G; Stolfo D; Sinagra G; Lund LH
    Nat Rev Cardiol; 2022 Feb; 19(2):100-116. PubMed ID: 34489589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum.
    Savarese G; Jonsson Å; Hallberg AC; Dahlström U; Edner M; Lund LH
    Int J Cardiol; 2020 Jan; 298():59-65. PubMed ID: 31521440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognosis of mid-range ejection fraction heart failure: a systematic review and meta-analysis.
    Altaie S; Khalife W
    ESC Heart Fail; 2018 Dec; 5(6):1008-1016. PubMed ID: 30211480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart failure with non-reduced ejection fraction: Epidemiology, pathophysiology, phenotypes, diagnosis and treatment approaches.
    Çavuşoğlu Y; Çelik A; Altay H; Nalbantgil S; Özden Ö; Temizhan A; Ural D; Ünlü S; Yılmaz MB; Zoghi M
    Turk Kardiyol Dern Ars; 2022 May; 50(Supp1):S1-S34. PubMed ID: 35969235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heart failure with mid-range ejection fraction: characterization of patients from the PINNACLE Registry®.
    Ibrahim NE; Song Y; Cannon CP; Doros G; Russo P; Ponirakis A; Alexanian C; Januzzi JL
    ESC Heart Fail; 2019 Aug; 6(4):784-792. PubMed ID: 31268631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Rickenbacher P; Kaufmann BA; Maeder MT; Bernheim A; Goetschalckx K; Pfister O; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2017 Dec; 19(12):1586-1596. PubMed ID: 28295985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.
    Abdul-Rahim AH; Shen L; Rush CJ; Jhund PS; Lees KR; McMurray JJV;
    Eur J Heart Fail; 2018 Jul; 20(7):1139-1145. PubMed ID: 29493058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mild and moderate to severe early acute kidney injury following cardiac surgery among patients with heart failure and preserved vs. mid-range vs. reduced ejection fraction: A retrospective cohort study.
    Gao Y; Wang C; Li J; Ji B; Wang J; Yan F; Wang Y
    Eur J Anaesthesiol; 2022 Aug; 39(8):673-684. PubMed ID: 35791895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-year mortality of heart failure with preserved, mildly reduced, and reduced ejection fraction in a 4880 Chinese cohort.
    Chen S; Huang Z; Liang Y; Zhao X; Aobuliksimu X; Wang B; He Y; Kang Y; Huang H; Li Q; Yao Y; Lu X; Qian X; Xie X; Liu J; Liu Y
    ESC Heart Fail; 2022 Aug; 9(4):2336-2347. PubMed ID: 35437939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 35. Sex-related differences in chronic heart failure: a community-based study.
    Russo G; Rea F; Barbati G; Cherubini A; Stellato K; Scagnetto A; Iorio A; Corrao G; Di Lenarda A
    J Cardiovasc Med (Hagerstown); 2021 Jan; 22(1):36-44. PubMed ID: 32740424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction.
    Santas E; de la Espriella R; Palau P; Miñana G; Amiguet M; Sanchis J; Lupón J; Bayes-Genís A; Chorro FJ; Núñez Villota J
    ESC Heart Fail; 2020 Jun; 7(3):1007-1014. PubMed ID: 32212327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with HFpEF and HFmrEF have different clinical characteristics in Turkey: A multicenter observational study.
    Özlek B; Özlek E; Ağuş HZ; Tekinalp M; Kahraman S; Çil C; Çelik O; Başaran Ö; Doğan V; Kaya BC; Rencüzoğulları I; Ösken A; Bekar L; Çakır MO; Çelik Y; Mert KU; Sancar KM; Sevinç S; Mert GÖ; Biteker M
    Eur J Intern Med; 2019 Mar; 61():88-95. PubMed ID: 30446354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart Failure with Mid-Range Ejection Fraction - State of the Art.
    Mesquita ET; Barbetta LMDS; Correia ETO
    Arq Bras Cardiol; 2019 Jul; 112(6):784-790. PubMed ID: 31314831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
    Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
    ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.